Rationale and design of a randomized phase 2 trial of gefitinib plus bevacizumab vs gefitinib alone in patients with epidermal growth factor receptor mutant non-squamous non-small-cell lung cancer: Study protocol

Chiyoe Kitagawa, Akiko Kada, Akiko M. Saito, Yukito Ichinose, Hideo Saka

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Rationale and design of a randomized phase 2 trial of gefitinib plus bevacizumab vs gefitinib alone in patients with epidermal growth factor receptor mutant non-squamous non-small-cell lung cancer: Study protocol'. Together they form a unique fingerprint.

Medicine & Life Sciences